Print

Purpose

We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Criteria


Inclusion Criteria:

- Ability and acceptance to provide written informed consent and fluent in English.

- Men or women between 18-100+ years, inclusive.

- Willing to comply with study procedures.

- SARS-CoV-2 positive test result as confirmed by a RT-PCR assay with a sputum or
nasopharyngeal sample (either done prior to or at the screening visit).

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Recruiting Locations

More Details

NCT ID
NCT04353401
Status
Completed
Sponsor
Vanda Pharmaceuticals

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.